World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
95
Citations
34486
World Ranking
534
National Ranking
248

Medicine

D-Index
107
Citations
46559
World Ranking
6196
National Ranking
3302

Stephen K. Tyring publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Stephen K. Tyring sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 623 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Stephen K. Tyring D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen K. Tyring sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 95 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Stephen K. Tyring is affiliated with The University of Texas Health Science Center at Houston in the United States. Their research primarily focuses on fields within Medicine, with a total of 196 publications. Key subfields of study include Dermatology, Immunology, Epidemiology, Genetics, and Rheumatology.

Their work covers a range of topics related to skin and immune system diseases. Main topics of research include:

  • Psoriasis: Treatment and Pathogenesis
  • Dermatology and Skin Diseases
  • Acne and Rosacea Treatments and Effects
  • Autoimmune Bullous Skin Diseases
  • Polyomavirus and related diseases
  • Herpesvirus Infections and Treatments
  • Skin Protection and Aging

Stephen K. Tyring has contributed to multiple publication venues frequently, including:

  • Journal of the American Academy of Dermatology
  • SKIN The Journal of Cutaneous Medicine
  • Archives of Dermatological Research
  • JAAD Case Reports
  • Journal of Drugs in Dermatology

Recent papers reflect a focus on dermatological clinical trials and immunological treatments. Notable publications include:

  • Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis, 2021, New England Journal of Medicine
  • A Randomized Placebo-Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate-to-Severe Plaque Psoriasis (VIP-S), 2020, Journal of Investigative Dermatology
  • One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial, 2022, Journal of the American Academy of Dermatology
  • Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a study, 2023, EClinicalMedicine
  • Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled, double-blind study, 2020, Journal of the American Academy of Dermatology

Throughout their career, Stephen K. Tyring has collaborated frequently with several co-authors including:

  • Linda Stein Gold
  • Peter L. Rady
  • Alfredo Siller
  • Leon Kircik
  • Kevin M. Burningham

Best Publications

  • Secukinumab in plaque psoriasis--results of two phase 3 trials.

    Richard G. Langley;Boni E. Elewski;Mark Lebwohl;Kristian Reich

  • Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

    Stephen Tyring;Alice Gottlieb;Kim Papp;Ken Gordon

  • Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

    Alan Menter;Stephen K. Tyring;Kenneth Gordon;Alexa B. Kimball

  • Recommendations for the management of herpes zoster.

    Robert H. Dworkin;Robert W. Johnson;Judith Breuer;John W. Gnann;John W. Gnann

  • Glycoprotein-D-adjuvant vaccine to prevent genital herpes.

    Lawrence R. Stanberry;Spotswood L. Spruance;Anthony L. Cunningham;David I. Bernstein

  • Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes

    Lawrence Corey;Anna Wald;Raj Patel;Stephen L. Sacks

  • The interferons. Mechanisms of action and clinical applications.

    Baron S;Tyring Sk;Fleischmann Wr;Coppenhaver Dh

  • Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

    Mark Lebwohl;Bruce Strober;Alan Menter;Kenneth Gordon

  • A global phase III randomized controlled trial of etanercept in psoriasis : safety, efficacy, and effect of dose reduction

    Kim A. Papp;S. Tyring;M. Lahfa;J. Prinz

  • A novel targeted T-cell modulator, efalizumab, for plaque psoriasis

    Mark Lebwohl;Stephen K. Tyring;Tiffani K. Hamilton;Darryl Toth

  • Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial

    Stephen Tyring;Rick A. Barbarash;James E. Nahlik;Anthony Cunningham

  • Recombinant Glycoprotein Vaccine for the Prevention of Genital HSV-2 Infection Two Randomized Controlled Trials

    Lawrence Corey;Andria G.M. Langenberg;Rhoda Ashley;Rose E. Sekulovich

  • Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

    Kristian Reich;Kim A Papp;Andrew Blauvelt;Stephen K Tyring

  • Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis.

    Kim A. Papp;Andrew Blauvelt;Michael Bukhalo;Melinda Gooderham

  • Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women.

    Anna Wald;Andria G. M. Langenberg;Katherine Link;Allen E. Izu

  • Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy.

    Ulrich R Hengge;Thomas Ruzicka;Stephen K Tyring;Martin Stuschke

  • Long-term Safety and Efficacy of 50 mg of Etanercept Twice Weekly in Patients With Psoriasis

    Stephen Tyring;Kenneth B. Gordon;Yves Poulin;Richard G. Langley

  • Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review.

    Elizabeth Y. Chiao;Elizabeth Y. Chiao;Thomas P. Giordano;Thomas P. Giordano;Joel M. Palefsky;Stephen Tyring

  • High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations.

    Jian Chao Zong;Dolores M. Ciufo;Donald J. Alcendor;Xiaoyu Wan

  • Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years.

    Romanowski B;de Borba Pc;Naud Ps

Frequent Co-Authors

Kim Papp
Kim Papp Probity Medical Research
Kenneth H. Fife
Kenneth H. Fife Indiana University
Andrew Blauvelt
Andrew Blauvelt Veterans Health Administration
Reuben Matalon
Reuben Matalon The University of Texas Medical Branch at Galveston
Anna Wald
Anna Wald University of Washington
Duane L. Pierson
Duane L. Pierson National Aeronautics and Space Administration
Brian Berman
Brian Berman Virginia Commonwealth University
Myron J. Levin
Myron J. Levin University of Colorado Anschutz Medical Campus
Kristian Reich
Kristian Reich University of Göttingen
Randall J. Cohrs
Randall J. Cohrs University of Colorado Anschutz Medical Campus

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Microbiology in the USA, exploring related healthcare and information management fields can open diverse career opportunities. Many students consider becoming a certified professional coder (cpc), a role that integrates medical knowledge with coding expertise to accurately categorize patient data and support healthcare billing processes.

Another promising path is Health Information Management. Professionals in this field oversee patient records and ensure compliance with healthcare regulations. Understanding the health information manager salary trends can help students assess long-term financial prospects in this growing sector.

To pursue these careers, choosing a reputable program is essential. Students can find top-quality education through a cahiim accredited health information management degree online. These programs offer the flexibility of remote learning while maintaining industry standards that employers value.

For those looking to enter the workforce quickly, the availability of shortest online medical billing and coding certificate programs can provide an efficient pathway to certification and employment. Balancing education with practical experience is key to building a successful career linked to microbiology and health information.

Best Scientists Citing Stephen K. Tyring

Trending Scientists